LeMaitre Vascular Files 8-K on Financials
Ticker: LMAT · Form: 8-K · Filed: May 1, 2025 · CIK: 1158895
| Field | Detail |
|---|---|
| Company | Lemaitre Vascular Inc (LMAT) |
| Form Type | 8-K |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
LeMaitre Vascular dropped an 8-K on May 1st covering financial results. Check it out.
AI Summary
LeMaitre Vascular, Inc. filed an 8-K on May 1, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the report date and date of change both listed as May 1, 2025. The company is incorporated in Delaware and headquartered in Burlington, MA.
Why It Matters
This filing provides an update on LeMaitre Vascular's financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing reporting on financial condition and results of operations, with no immediate negative or positive events indicated.
Key Players & Entities
- LeMaitre Vascular, Inc. (company) — Registrant
- May 1, 2025 (date) — Date of Report
- Burlington, MA (location) — Principal Executive Offices
- 001-33092 (other) — Commission File Number
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this report filed and what is the earliest event date?
The report was filed as of May 1, 2025, and the date of the earliest event reported is also May 1, 2025.
Where is LeMaitre Vascular, Inc. headquartered?
The principal executive offices are located at 63 Second Avenue, Burlington, MA 01803.
What is the company's Commission File Number?
The Commission File Number for LeMaitre Vascular, Inc. is 001-33092.
Under which section of the Securities Exchange Act is this report filed?
This is a Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding LEMAITRE VASCULAR INC (LMAT).